焦点细分质结核病研究的进展:非编码RNAs的遗传原因
Maryam Esmaeilzadeh Aghjeh1,2, Ilknur Suer3, Ahmet Burak Dirim4
1Division of Medical Genetics, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. es_maryam70@yahoo.com.
Molecular biology reports
|April 10, 2025
概括
焦点细分细胞凝结症 (FSGS) 涉及细胞损伤,导致功能衰竭. 像miRNAs和circRNAs这样的非编码RNA显示为早期FSGS诊断和监测的生物标志物,提供新的治疗途径.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 焦点细分细胞凝聚硬化 (FSGS) 是一种脏疾病,导致细胞损伤和蛋白尿,通常导致末期脏疾病 (ESRD).
- 目前的治疗依赖于免疫抑制剂,有效性和副作用各不相同,需要新的治疗策略.
- 遗传因素,特别是细胞相关蛋白质,在FSGS病变发生过程中发挥着重要作用.
研究的目的:
- 审查了解FSGS遗传和分子基础的最新进展.
- 突出非编码RNA作为FSGS诊断和疾病监测的生物标记物的潜力.
- 根据FSGS所涉及的分子途径确定新的治疗点.
主要方法:
- 对最近关于FSGS遗传学和分子生物学研究的文献综述.
- 对非编码RNAs (miRNAs,circRNAs,lncRNAs) 在FSGS中的作用的数据分析.
- 结合与生物标志物发现和治疗标识别相关的发现.
主要成果:
- 失调的microRNAs (miRNAs) 和循环RNAs (circRNAs) 显示出作为FSGS的诊断和监测生物标志物的潜力.
- 长非编码RNAs (lncRNAs) 参与基因表达调制和 podocyte 功能,提供潜在的治疗点.
- 细胞相关蛋白的基因组变化是FSGS发展的关键.
结论:
- 非编码RNA代表FSGS生物标志物开发和治疗创新的一个有希望的领域.
- 对lncRNA介导途径的进一步研究可能会导致FSGS的向治疗.
- 了解FSGS的遗传基础对于推进诊断和治疗方法至关重要.
更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12.9K
10:25Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
1.7K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
01:11Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K
01:05Single Nucleotide Polymorphisms-SNPs
13.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.7K